Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Todd

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Research|January 1, 1986
Identification of a differentiation-specific cell surface antigen on HL60 cells that is associated with proliferationM B Todd, H L Malech
Seminars in Oncology|February 1, 1989
Therapeutic options in renal cell carcinomaA C Buzaid, M B Todd
The Journal of Urology|July 1, 1995
Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiersS Mani, M B Todd, K Katz, et al.
The Journal of Urology|January 1, 1990
Malignant rhabdoid tumor of the kidney in an adultW Lowe, R M Weiss, M B Todd, et al.
Biochemistry|January 29, 1985
Isolation and functional effects of monoclonal antibodies binding to thymidylate synthaseM M Jastreboff, M B Todd, H L Malech, et al.
Oncology Research|January 1, 1994
Procoagulant activity in cancer cells is dependent on tissue factor expressionT Hu, R R Bach, R Horton, et al.
Thrombosis Research|October 15, 1993
Synthesis of tissue factor messenger RNA and procoagulant activity in breast cancer cells in response to serum stimulationT Hu, R R Bach, R Horton, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1986
Prognostic indicators in diffuse large-cell (histiocytic) lymphomaM B Todd, C S Portlock, L R Farber, et al.
Blood|October 15, 1990
The role of cellular maturation in neutrophil heterogeneityP J Krause, M B Todd, W W Hancock, et al.
Seminars in Oncology|February 1, 1989
A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemiaP H Wiernik, D C Case, P O Periman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Research|January 1, 1986
Identification of a differentiation-specific cell surface antigen on HL60 cells that is associated with proliferationM B Todd, H L Malech
Seminars in Oncology|February 1, 1989
Therapeutic options in renal cell carcinomaA C Buzaid, M B Todd
The Journal of Urology|July 1, 1995
Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiersS Mani, M B Todd, K Katz, et al.
The Journal of Urology|January 1, 1990
Malignant rhabdoid tumor of the kidney in an adultW Lowe, R M Weiss, M B Todd, et al.
Biochemistry|January 29, 1985
Isolation and functional effects of monoclonal antibodies binding to thymidylate synthaseM M Jastreboff, M B Todd, H L Malech, et al.
Oncology Research|January 1, 1994
Procoagulant activity in cancer cells is dependent on tissue factor expressionT Hu, R R Bach, R Horton, et al.
Thrombosis Research|October 15, 1993
Synthesis of tissue factor messenger RNA and procoagulant activity in breast cancer cells in response to serum stimulationT Hu, R R Bach, R Horton, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1986
Prognostic indicators in diffuse large-cell (histiocytic) lymphomaM B Todd, C S Portlock, L R Farber, et al.
Blood|October 15, 1990
The role of cellular maturation in neutrophil heterogeneityP J Krause, M B Todd, W W Hancock, et al.
Seminars in Oncology|February 1, 1989
A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemiaP H Wiernik, D C Case, P O Periman, et al.
Pageof 2